drugset / Trial / NCT02923128

Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction

NCT02923128

Phase 4 Completed 240 enrolled Zhejiang Cancer Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether postoperative analgesia pump continuous infusion of dexmedetomidine are effective in the prevention of Postoperative delirium and Postoperative cognitive dysfunction.

Timeline

Start
2016-11
Primary completion
2020-10
Completion
2020-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 3 ug/kg
Comparator Sufentanil Other / unclassified 3 ug/kg